European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD

BMC Psychiatry

Volumn 10, Issue , 2010, Pages

  Kooij, Sandra J J ^a   Bejerot, Susanne ^b   Blackwell, Andrew ^c   Caci, Herve ^d   Casas Brugué, Miquel ^e   Carpentier, Pieter J ^f   Edvinsson, Dan ^a   Fayyad, John ^g   Foeken, Karin ^h   Fitzgerald, Michael ⁱ   Gaillac, Veronique ^j   Ginsberg, Ylva ^k   Henry, Chantal ^l   Krause, Johanna ^m   Lensing, Michael B ⁿ   Manor, Iris ^o   Niederhofer, Helmut ^p   Nunes Filipe, Carlos ^q   Ohlmeier, Martin D ^r   Oswald, Pierre ^s   Pallanti, Stefano ^t   Pehlivanidis, Artemios ^u   Ramos Quiroga, Josep A ^e   Rastam, Maria ^v   Ryffel Rawak, Doris ^a   Stes, Steven ^w   Asherson, Philip ^x   more..

^a Department Adult ADHD ^*  (Switzerland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL OF NICE   (France)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f Reinier Van Arkel Groep   (Netherlands)

^g SAINT GEORGE HOSPITAL UNIVERSITY MEDICAL CENTER   (Lebanon)

^h INSTITUT ARNAULT TZANCK   (France)

ⁱ TRINITY COLLEGE DUBLIN   (Ireland)

^j CENTRE HOSPITALIER SAINTE ANNE   (France)

^k Affektiva mottagningen   (Sweden)

^l CENTRE HOSPITALIER CHARLES PERRENS   (France)

^m Private clinic for psychiatry and psychotherapy   (Germany)

ⁿ ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^o TEL AVIV UNIVERSITY   (Israel)

^p CENTRAL HOSPITAL OF BOLZANO   (Italy)

^q UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^r HANNOVER MEDICAL SCHOOL   (Germany)

^s BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^t UNIVERSITY OF FLORENCE   (Italy)

^u NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^v LUND UNIVERSITY   (Sweden)

^w UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^x KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER; CHILD; COMPARATIVE STUDY; CONSENSUS; DISEASE COURSE; EUROPE; FEMALE; HUMAN; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; PSYCHOTHERAPY; REVIEW; STANDARD;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COMBINED MODALITY THERAPY; CONSENSUS; DISEASE PROGRESSION; EUROPE; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PSYCHOTHERAPY;

EID: 77956485676     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-10-67     Document Type: Article

References (320)

1. Hill JC, Schoener EP. Age-dependent decline of attention deficit hyperactivity disorder. Am J Psychiatry 1996, 153(9):1143-1146.
2. Wood DR, Reimherr FW, Wender PH, Johnson GE. Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Arch Gen Psychiatry 1976, 33(12):1453-1460.
3. Lara C, Fayyad J, de Graaf R, Kessler RC, Aguilar-Gaxiola S, Angermeyer M, Demytteneare K, de Girolamo G, Haro JM, Jin R, et al. Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol Psychiatry 2009, 65(1):46-54. 10.1016/j.biopsych.2008.10.005, 2629074, 19006789.
4. Lie N. Follow-ups of children with attention deficit hyperactivity disorder (ADHD). Review of literature. Acta Psychiatr Scand Suppl 1992, 368:1-40.
5. Gittelman R, Mannuzza S, Shenker R, Bonagura N. Hyperactive boys almost grown up. I. Psychiatric status. Arch Gen Psychiatry 1985, 42(10):937-947.
6. Weiss G, Hechtman L, Milroy T. Psychiatric status of hyperactives as adults: A controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry 1985, 24:211-220. 10.1016/S0002-7138(09)60450-7, 3989165.
7. Mannuzza S, Klein RG, Addalli KA. Young adult mental status of hyperactive boys and their brothers: a prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1991, 30(5):743-751. 10.1097/00004583-199109000-00008, 1938789.
8. Mannuzza S, Klein RG, Bessler A, Malloy P, et al. Adult outcome of hyperactive boys: Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993, 50(7):565-576.
9. Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 2002, 111(2):279-289. 10.1037/0021-843X.111.2.279, 12003449.
10. Mannuzza S, Klein RG, Moulton JL. Persistence of Attention-Deficit/Hyperactivity Disorder into adulthood: what have we learned from the prospective follow-up studies?. J Atten Disord 2003, 7(2):93-100. 10.1177/108705470300700203, 15018358.
11. Rasmussen P, Gillberg C. Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. Journal of the American Academy of Child and Adolescent Psychiatry 2000, 39(11):1424-1431. 10.1097/00004583-200011000-00017, 11068898.
12. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006, 36(2):159-165. 10.1017/S003329170500471X, 16420712.
13. Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 2000, 157(5):816-818. 10.1176/appi.ajp.157.5.816, 10784477.
14. Taylor E, Chadwick O, Heptinstall E, Danckaerts M. Hyperactivity and conduct problems as risk factors for adolescent development. Journal of the American Academy of Child and Adolescent Psychiatry 1996, 35(9):1213-1226. 10.1097/00004583-199609000-00019, 8824065.
15. Biederman J, Faraone S, Milberger S, Curtis S, Chen L, Marrs A, Ouellette C, Moore P, Spencer T. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry 1996, 35(3):343-351. 10.1097/00004583-199603000-00016, 8714323.
16. Simon V, Czobor P, Balint S, Meszaros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 2009, 194(3):204-211. 10.1192/bjp.bp.107.048827, 19252145.
17. Kooij JJS, Buitelaar JK, van den Oord EJ, Furer JW, Rijnders CAT, Hodiamont PPG. Internal and external validity of Attention-Deficit Hyperactivity Disorder in a population-based sample of adults. Psychol Med 2005, 35(6):817-827. 10.1017/S003329170400337X, 15997602.
18. Kessler RC, Adler LE, Ames M, Barkley RA, Birnbaum H, Greenberg P, Johnston JA, Spencer T, Ustun TB. The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med 2005, 47(6):565-572. 10.1097/01.jom.0000166863.33541.39, 15951716.
19. Fayyad J, de Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007, 190:402-409. 10.1192/bjp.bp.106.034389, 17470954.
20. Faraone SV, Biederman J, Monuteaux MC. Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genetic epidemiology 2000, 18(1):1-16. 10.1002/(SICI)1098-2272(200001)18:1<1::AID-GEPI1>3.0.CO;2-X, 10603455.
21. Faraone SV, Doyle AE, Knoerzer JA. Heritability of attention-deficit/hyperactivity disorder. Economics of Neuroscience 2001, 3(5):54-57.
22. Kessler RC. Comorbidity patterns in a community sample of adults with ADHD: results from the National Comorbidity Survey Replication. APA 160th Annual Meeting 2007,
23. Mancini C, Van Ameringen M, Oakman J, Figueiredo D. Childhood attention deficit/hyperactivity disorder in adults with anxiety disorders. Psychol Med 1999, 29(3):515-525. 10.1017/S0033291798007697, 10405074.
24. Fones CS, Pollack MH, Susswein L, Otto M. History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder. J Affect Disord 2000, 58(2):99-106.
25. Alpert JE, Maddocks A, Nierenberg AA, O'Sullivan R, Pava JA, Worthington JJ, Biederman J, Rosenbaum JF, Fava M. Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Res 1996, 62(3):213-219. 10.1016/0165-1781(96)02912-5, 8804131.
26. Fossati A, Novella L, Donati D, Donini M, Maffei C. History of childhood attention deficit/hyperactivity disorder symptoms and borderline personality disorder: a controlled study. ComprPsychiatry 2002, 43(5):369-377.
27. Goossensen M, van de Glind G, Carpentier P-J, Wijsen RM, van Duin D, Kooij J. An intervention program for ADHD in patients with substance use disorders: Preliminary results of a field trial. J Subst Abuse Treat 2006, 30(3):253-259. 10.1016/j.jsat.2005.12.004, 16616170.
28. Foreman DM, Foreman D, Prendergast M, Minty B. Is clinic prevalence of ICD-10 hyperkinesis underestimated? Impact of increasing awareness by a questionnaire screen in an UK clinic. Eur Child Adolesc Psychiatry 2001, 10(2):130-134.
29. Weiss M, Hechtman L, Weiss G. ADHD in parents. JAmAcadChild AdolescPsychiatry 2000, 39(8):1059-1061.
30. Faraone SV, Biederman J, Feighner JA, Monuteaux MC. Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid?. J Consult Clin Psychol 2000, 68(5):830-842. 10.1037/0022-006X.68.5.830, 11068969.
31. McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, Sayal K, de Soysa R, Taylor E, Williams T, et al. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 2009, 194(3):273-277. 10.1192/bjp.bp.107.045245, 19252159.
32. NICE Attention Deficit Hyperactivity Disorder: The NICE guideline on diagnosis and managment of ADHD in children, young people and adults 2008, The British Psychological Society and The Royal College of Psychiatrists, NICE.
33. Ebert D, Krause J, Roth-Sackenheim C. ADHD in adulthood - guidelines based on expert consensus with DGPPN support (German). Nervenarzt 2003, 74(939):946.
34. Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K, Morris KA, Santosh P, Sonuga-Barke E, Taylor E, et al. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2007, 21(1):10-41. 10.1177/0269881106073219, 17092962.
35. Wender PH, Wolf LE, Wasserstein J. Adults with ADHD. An overview. Ann NY Acad Sci 2001, 931:1-16.
36. Hart EL, Lahey BB, Loeber R, Applegate B, Frick PJ. Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study. J Abnorm Child Psychol 1995, 23(6):729-749.
37. Kooij JJS, Aeckerlin LP, Buitelaar JK. Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a Psychiatric Outpatients' Department. [Dutch]. Nederlands Tijdschrift voor Geneeskunde 2001, 145(31):1498-1501.
38. Fischer M, Barkley RA, Smallish L, Fletcher K. Executive functioning in hyperactive children as young adults: attention, inhibition, response perseveration, and the impact of comorbidity. Dev Neuropsychol 2005, 27(1):107-133. 10.1207/s15326942dn2701_5, 15737944.
39. Brown TE. Brown Attention-Deficit Disorder Scales. Manual 1996, San Antonio: The Psychological Corporation.
40. Buitelaar JK. [Discussion of attention deficit-hyperactivity disorder (ADHD): facts, opinions and emotions]. Ned Tijdschr Geneeskd 2001, 145(31):1485-1489.
41. Biederman J, Faraone SV, Spencer T, Wilens T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993, 150(12):1792-1798.
42. Stockl KM, Hughes TE, Jarrar MA, Secnik K, Perwien AR. Physician perceptions of the use of medications for attention deficit hyperactivity disorder. J Manag Care Pharm 2003, 9(5):416-423.
43. Asherson P, Chen W, Craddock B, Taylor E. Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry. Br J Psychiatry 2007, 190:4-5. 10.1192/bjp.bp.106.026484, 17197649.
44. Pescosolido BA, Jensen PS, Martin JK, Perry BL, Olafsdottir S, Fettes D. Public knowledge and assessment of child mental health problems: findings from the National Stigma Study-Children. J Am Acad Child Adolesc Psychiatry 2008, 47(3):339-349. 10.1097/CHI.0b013e318160e3a0, 18216729.
45. Lanham JS. The evaluation of attention deficit/hyperactivity disorder in family medicine residency programs. South Med J 2006, 99(8):802-805. 10.1097/01.smj.0000215738.43515.c7, 16929872.
46. Faraone SV, Doyle AE. The nature and heritability of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2001, 10(2):299-292ix.
47. Faraone SV. Genetics of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2004, 27:303-321.
48. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57(11):1313-1323. 10.1016/j.biopsych.2004.11.024, 15950004.
49. Sprich S, Biederman J, Crawford MH, Mundy E, Faraone SV. Adoptive and biological families of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry 2000, 39(11):1432-1437. 10.1097/00004583-200011000-00018, 11068899.
50. Moore J, Fombonne E. Psychopathology in adopted and nonadopted children: a clinical sample. Am J Orthopsychiatry 1999, 69(3):403-409. 10.1037/h0080415, 10439855.
51. Gilger JW, Pennington BF, DeFries JC. A twin study of the etiology of comorbidity: attention-deficit hyperactivity disorder and dyslexia. J Am Acad Child Adolesc Psychiatry 1992, 31(2):343-348.
52. Sherman DK, Iacono WG, McGue MK. Attention-deficit hyperactivity disorder dimensions: a twin study of inattention and impulsivity-hyperactivity. J Am Acad Child Adolesc Psychiatry 1997, 36(6):745-753.
53. Rietveld MJ, Hudziak JJ, Bartels M, CE, Boomsma DI. Heritability of attention problems in children: longitudinal results from a study of twins, age 3 to 12. J Child Psychol Psychiatry 2004, 45(3):577-588. 10.1111/j.1469-7610.2004.00247.x, 15055376.
54. Levy F, Hay DA, McStephen M, Wood C, Waldman I. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 1997, 36(6):737-744. 10.1097/00004583-199706000-00009, 9183127.
55. Stevens SE, Sonuga-Barke EJ, Kreppner JM, Beckett C, Castle J, Colvert E, Groothues C, Hawkins A, Rutter M. Inattention/overactivity following early severe institutional deprivation: presentation and associations in early adolescence. J Abnorm Child Psychol 2008, 36(3):385-398. 10.1007/s10802-007-9185-5, 17965931.
56. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57(11):1313-1323. 10.1016/j.biopsych.2004.11.024, 15950004.
57. Kuntsi J, Rijsdijk F, Ronald A, Asherson P, Plomin R. Genetic influences on the stability of attention-deficit/hyperactivity disorder symptoms from early to middle childhood. Biol Psychiatry 2005, 57(6):647-654. 10.1016/j.biopsych.2004.12.032, 15780852.
58. Larsson JO, Larsson H, Lichtenstein P. Genetic and environmental contributions to stability and change of ADHD symptoms between 8 and 13 years of age: a longitudinal twin study. Journal of the American Academy of Child and Adolescent Psychiatry 2004, 43(10):1267-1275. 10.1097/01.chi.0000135622.05219.bf, 15381894.
59. van den Berg SM, Willemsen G, de Geus EJ, Boomsma DI. Genetic etiology of stability of attention problems in young adulthood. Am J Med Genet B Neuropsychiatr Genet 2006, 141B(1):55-60. 10.1002/ajmg.b.30251, 16287044.
60. Boomsma DI, Saviouk V, Hottenga JJ, Distel MA, de Moor MH, Vink JM, Geels LM, van Beek JH, Bartels M, de Geus EJ, et al. Genet epidemiol of attention deficit hyperactivity disorder (ADHD index) in adults. PloS one 2010, 5(5):e10621. 10.1371/journal.pone.0010621, 2868902, 20485550.
61. Halperin JM, Schulz KP. Revisiting the role of the prefrontal cortex in the pathophysiology of attention-deficit/hyperactivity disorder. Psychological bulletin 2006, 132(4):560-581. 10.1037/0033-2909.132.4.560, 16822167.
62. Halperin JM, Trampush JW, Miller CJ, Marks DJ, Newcorn JH. Neuropsychological outcome in adolescents/young adults with childhood ADHD: profiles of persisters, remitters and controls. Journal of child psychology and psychiatry, and allied disciplines 2008, 49(9):958-966. 10.1111/j.1469-7610.2008.01926.x, 2646044, 18573145.
63. Kuntsi J, Wood AC, Rijsdijk F, Johnson KA, Andreou P, Albrecht B, Arias Vasquez A, Buitelaar J, McLoughlin G, Rommelse N, et al. Seperation of cognitive impairments in attention deficit hyperactivity disorder into two familial factors. Arch Gen Psychiatry 2010,
64. Li D, Sham PC, Owen MJ, He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Human molecular genetics 2006, 15(14):2276-2284. 10.1093/hmg/ddl152, 16774975.
65. Kuntsi J, Neale BM, Chen W, Faraone SV, Asherson P. The IMAGE project: methodological issues for the molecular genetic analysis of ADHD. Behav Brain Funct 2006, 2:27. 10.1186/1744-9081-2-27, 1559631, 16887023.
66. Franke B, Neale BM, Faraone SV. Genome-wide association studies in ADHD. Human genetics 2009, 126(1):13-50. 10.1007/s00439-009-0663-4, 19384554.
67. Franke B, Hoogman M, Arias Vasquez A, Heister JG, Savelkoul PJ, Naber M, Scheffer H, Kiemeney LA, Kan CC, Kooij JJ, et al. Association of the dopamine transporter (SLC6A3/DAT1) gene 9-6 haplotype with adult ADHD. Am J Med Genet B Neuropsychiatr Genet 2008, 147B(8):1576-1579. 10.1002/ajmg.b.30861, 18802924.
68. Johansson S, Halmoy A, Mavroconstanti T, Jacobsen KK, Landaas ET, Reif A, Jacob C, Boreatti-Hummer A, Kreiker S, Lesch KP, et al. Common variants in the TPH1 and TPH2 regions are not associated with persistent ADHD in a combined sample of 1,636 adult cases and 1,923 controls from four European populations. Am J Med Genet B Neuropsychiatr Genet 2010, 153B(5):1008-15.
69. Landaas ET, Johansson S, Jacobsen KK, Ribases M, Bosch R, Sanchez-Mora C, Jacob CP, Boreatti-Hummer A, Kreiker S, Lesch KP, et al. An international multicenter association study of the serotonin transporter gene in persistent ADHD. Genes, brain, and behavior 2010, 9(5):449-58.
70. Sanchez-Mora C, Ribases M, Ramos-Quiroga JA, Casas M, Bosch R, Boreatti-Hummer A, Heine M, Jacob CP, Lesch KP, Fasmer OB, et al. Meta-analysis of brain-derived neurotrophic factor p.Val66Met in adult ADHD in four European populations. Am J Med Genet B Neuropsychiatr Genet 153B(2):512-523.
71. Ribases M, Hervas A, Ramos-Quiroga JA, Bosch R, Bielsa A, Gastaminza X, Fernandez-Anguiano M, Nogueira M, Gomez-Barros N, Valero S, et al. Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder. Biol Psychiatry 2008, 63(10):935-945. 10.1016/j.biopsych.2007.11.004, 18179783.
72. Ribases M, Ramos-Quiroga JA, Hervas A, Bosch R, Bielsa A, Gastaminza X, Artigas J, Rodriguez-Ben S, Estivill X, Casas M, et al. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Molecular psychiatry 2009, 14(1):71-85. 10.1038/sj.mp.4002100, 17938636.
73. Banerjee TD, Middleton F, Faraone SV. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr 2007, 96(9):1269-1274. 10.1111/j.1651-2227.2007.00430.x, 17718779.
74. Milberger S, Biederman J, Faraone SV, Chen L, Jones J. Further evidence of an association between attention-deficit/hyperactivity disorder and cigarette smoking. Findings from a high-risk sample of siblings. Am J Addict 1997, 6(3):205-217.
75. Milberger S, Biederman J, Faraone SV, Guite J, Tsuang MT. Pregnancy, delivery and infancy complications and attention deficit hyperactivity disorder: issues of gene-environment interaction. Biol Psychiatry 1997, 41(1):65-75. 10.1016/0006-3223(95)00653-2, 8988797.
76. Botting N, Powls A, Cooke RW, Marlow N. Attention deficit hyperactivity disorders and other psychiatric outcomes in very low birthweight children at 12 years. J Child Psychol Psychiatry 1997, 38(8):931-941.
77. Thapar A, Rice F, Hay D, Boivin J, Langley K, van den Bree M, Rutter M, Harold G. Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design. Biol Psychiatry 2009, 66(8):722-727. 10.1016/j.biopsych.2009.05.032, 2756407, 19596120.
78. Bekker EM, Overtoom CC, Kenemans JL, Kooij JJ, De Noord I, Buitelaar JK, Verbaten MN. Stopping and changing in adults with ADHD. Psychol Med 2005, 35(6):807-816. 10.1017/S0033291704003459, 15997601.
79. Bekker EM, Kenemans JL, Hoeksma MR, Talsma D, Verbaten MN. The pure electrophysiology of stopping. International Journal of Psychophysiology 2005, 55(2):191-8. 10.1016/j.ijpsycho.2004.07.005, 15649550.
80. Seidman LJ, Valera EM, Bush G. Brain function and structure in adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2004, 27(2):323-347. 10.1016/j.psc.2004.01.002, 15064000.
81. Seidman LJ, Doyle A, Fried R, Valera E, Crum K, Matthews L. Neuropsychological function in adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am 2004, 27(2):261-282. 10.1016/j.psc.2003.12.005, 15063997.
82. Seidman LJ, Valera EM, Makris N. Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57(11):1263-1272. 10.1016/j.biopsych.2004.11.019, 15949998.
83. Krause J. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder. Expert Rev Neurother 2008, 8(4):611-625. 10.1586/14737175.8.4.611, 18416663.
84. Biederman J, Faraone SV. Current concepts on the neurobiology of Attention-Deficit/Hyperactivity Disorder. J Atten Disord 2002, 6(Suppl 1):S7-16.
85. Krause KH, Dresel SH, Krause J, la Fougere C, Ackenheil M. The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neuroscience & Biobehavioral Reviews 2003, 27(7):605-613.
86. Spencer TJ, Biederman J, Madras BK, Dougherty DD, Bonab AA, Livni E, Meltzer PC, Martin J, Rauch S, Fischman AJ. Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. Biol Psychiatry 2007, 62(9):1059-1061. 10.1016/j.biopsych.2006.12.008, 2715944, 17511972.
87. Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B, Hechtman L, Epstein JN, Pelham WE, Abikoff HB, et al. Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. Journal of the American Academy of Child and Adolescent Psychiatry 2007, 46(8):1015-1027. 10.1097/chi.0b013e3180686d7e, 17667480.
88. Volkow ND, Wang GJ, Newcorn J, Fowler JS, Telang F, Solanto MV, Logan J, Wong C, Ma Y, Swanson JM, et al. Brain dopamine transporter levels in treatment and drug naive adults with ADHD. Neuroimage 2007, 34(3):1182-1190. 10.1016/j.neuroimage.2006.10.014, 17126039.
89. Seidman LJ, Valera EM, Makris N, Monuteaux MC, Boriel D, Kelkar K, Kennedy DN, Caviness VS, Bush G, Aleardi M, et al. Dorsolateral Prefrontal and Anterior Cingulate Cortex Volumetric Abnormalities in Adults with Attention-Deficit/Hyperactivity Disorder Identified by Magnetic Resonance Imaging. Biol Psychiatry 2006, 60(10):1071-1080. 10.1016/j.biopsych.2006.04.031, 16876137.
90. Valera EM, Faraone SV, Murray KE, Seidman LJ. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry 2007, 61(12):1361-1369. 10.1016/j.biopsych.2006.06.011, 16950217.
91. Makris N, Biederman J, Valera EM, Bush G, Kaiser J, Kennedy DN, Caviness VS, Faraone SV, Seidman LJ. Cortical Thinning of the Attention and Executive Function Networks in Adults with Attention-Deficit/Hyperactivity Disorder. Cerebral Cortex 2007, 17(6):1364-1375. 10.1093/cercor/bhl047, 16920883.
92. Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, Sarfatti SE, Vauss YC, Snell JW, Lange N, et al. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1996, 53(7):607-616.
93. Castellanos FX, Giedd JN, Berquin PC, Walter JM, Sharp W, Tran T, Vaituzis AC, Blumenthal JD, Nelson J, Bastain TM, et al. Quantitative brain magnetic resonance imaging in girls with attention- deficit/hyperactivity disorder. ArchGenPsychiatry 2001, 58(3):289-295.
94. Castellanos FX. Anatomic magnetic resonance imaging studies of attention-deficit/hyperactivity disorder. Dialogues in Clinical Neuroscience 2002, 4(4):444-448.
95. Semrud-Clikeman M, Filipek PA, Biederman J, Steingard R, Kennedy D, Renshaw P, Bekken K. Attention-deficit hyperactivity disorder: magnetic resonance imaging morphometric analysis of the corpus callosum. J Am Acad Child Adolesc Psychiatry 1994, 33(6):875-881. 10.1097/00004583-199407000-00014, 8083145.
96. Durston S, Pol HE, Schnack HG, Buitelaar JK, Steenhuis MP, Minderaa RB, Kahn RS, van Engeland H. Magnetic resonance imaging of boys with attention-deficit/hyperactivity disorder and their unaffected siblings. Child & Adolescent Social Work Journal 2004, 21(1):332-340.
97. Durston S. Converging methods in studying attention-deficit/hyperactivity disorder: what can we learn from neuroimaging and genetics?. Dev Psychopathol 2008, 20(4):1133-1143. 10.1017/S0954579408000539, 18838034.
98. Makris N, Buka SL, Biederman J, Papadimitriou GM, Hodge SM, Valera EM, Brown AB, Bush G, Monuteaux MC, Caviness VS, et al. Attention and executive systems abnormalities in adults with childhood ADHD: A DT-MRI study of connections. Cereb Cortex 2008, 18(5):1210-1220. 10.1093/cercor/bhm156, 17906338.
99. Bush G, Frazier JA, Rauch SL, Seidman LJ, Whalen PJ, Jenike MA, Rosen BR, Biederman J. Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry 1999, 45(12):1542-1552. 10.1016/S0006-3223(99)00083-9, 10376114.
100. Suskauer SJ, Simmonds DJ, Fotedar S, Blankner JG, Pekar JJ, Denckla MB, Mostofsky SH. Functional magnetic resonance imaging evidence for abnormalities in response selection in attention deficit hyperactivity disorder: differences in activation associated with response inhibition but not habitual motor response. J Cogn Neurosci 2008, 20(3):478-493. 10.1162/jocn.2008.20032, 2896028, 18004945.
101. Paloyelis Y, Mehta MA, Kuntsi J, Asherson P. Functional MRI in ADHD: a systematic literature review. Expert review of neurotherapeutics 2007, 7(10):1337-1356. 10.1586/14737175.7.10.1337, 17939771.
102. Pliszka SR, Glahn DC, Semrud-Clikeman M, Franklin C, Perez R, Xiong J, Liotti M. Neuroimaging of inhibitory control areas in children with attention deficit hyperactivity disorder who were treatment naive or in long-term treatment. The Am J Psychiatry 2006, 163(6):1052-1060. 10.1176/appi.ajp.163.6.1052, 16741206.
103. Rubia K, Smith AB, Brammer MJ, Toone B, Taylor E. Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD. The Am J Psychiatry 2005, 162(6):1067-1075. 10.1176/appi.ajp.162.6.1067, 15930054.
104. Zametkin AJ, Nordahl TE, Gross M, King A, et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. New England Journal of Medicine 1990, 323(20):1361-1366. 10.1056/NEJM199011153232001, 2233902.
105. Zametkin AJ, Liebenauer LL, Fitzgerald GA, King AC, Minkunas DV, Herscovitch P, Yamada EM, Cohen RM. Brain metabolism in teenagers with attention-deficit hyperactivity disorder. ArchGenPsychiatry 1993, 50(5):333-340.
106. Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J Neurosci 1998, 18(15):5901-5907.
107. Lou HC, Henriksen L, Bruhn P, Borner H, Nielsen JB. Striatal dysfunction in attention deficit and hyperkinetic disorder. Archives of Neurology 1989, 46(1):48-52.
108. Amen DG, Hanks C, Prunella J. Preliminary evidence differentiating ADHD using brain SPECT imaging in older patients. J Psychoactive Drugs 2008, 40(2):139-146.
109. Wilens TE, Decker MW. Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: Focus on cognition. Biochem Pharmacol 2007, 7:7.
110. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K, Ackenheil M. Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder. Int J Neuropsychopharmacol 2002, 5(2):111-113. 10.1017/S1461145702002821, 12135534.
111. Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F, Fowler JS, Zhu W, Logan J, Ma Y, et al. Evaluating dopamine reward pathway in ADHD: clinical implications. Jama 2009, 302(10):1084-1091. 10.1001/jama.2009.1308, 19738093.
112. APA American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. Washington DC 1994, 4, APA.
113. Tripp G, Luk SL, Schaughency EA, Singh R. DSM-IV and ICD-10: a comparison of the correlates of ADHD and hyperkinetic disorder. JAmAcadChild AdolescPsychiatry 1999, 38(2):156-164.
114. Faraone SV, Sergeant J, Gillberg C. The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry 2003, 2:104-113. 1525089, 16946911.
115. Lee SI, Schachar RJ, Chen SX, Ornstein TJ, Charach A, Barr C, Ickowicz A. Predictive validity of DSM-IV and ICD-10 criteria for ADHD and hyperkinetic disorder. J Child Psychol Psychiatry 2008, 49(1):70-78. 10.1111/j.1469-7610.2007.01784.x, 17979965.
116. Asherson P. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert review of neurotherapeutics 2005, 5(4):525-539. 10.1586/14737175.5.4.525, 16026236.
117. Kooij JJS. ADHD in adults. Clinical studies on assessment and treatment. 2006, Radboud University Nijmegen.
118. Skirrow C, McLoughlin G, Kuntsi J, Asherson P. Behavioral, neurocognitive and treatment overlap between attention-deficit/hyperactivity disorder and mood instability. Expert review of neurotherapeutics 2009, 9(4):489-503. 10.1586/ern.09.2, 19344301.
119. Biederman J, Petty CR, Fried R, Kaiser R, Dolan CR, Schoenfeld S, Doyle AE, Seidman LJ, Faraone SV. Educational and occupational underattainment in adults with attention-deficit/hyperactivity disorder: a controlled study. J Clin Psychiatry 2008, 69(8):1217-1222. 10.4088/JCP.v69n0803, 18681752.
120. de Graaf R, Kessler RC, Fayyad J, ten Have M, Alonso J, Angermeyer M, Borges G, Demyttenaere K, Gasquet I, de Girolamo G, et al. The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med 2008, 65(12):835-842. 10.1136/oem.2007.038448, 2665789, 18505771.
121. Murphy K, Barkley RA. Attention deficit hyperactivity disorder in adults: comorbidities and adaptive impairments. ComprPsychiatry 1996, 37(6):393-401.
122. Barkley R, Gordon M. Research on comorbidity, adaptive functioning, and cognitive impairments in adults with ADHD: Implications for a clinical practice. Clinicians' guide to adult ADHD: Assessment and intervention 2002, 43-69. San Diego, CA: Academic Press, Inc, Goldstein S, Ellison AT.
123. Robin LA. The impact of ADHD on marriage. The ADHD Report 2002, 10(3):9-14.
124. Fischer M, Barkley RA, Smallish L, Fletcher K. Hyperactive children as young adults: Driving abilities, safe driving behavior, and adverse driving outcomes. Accident; Analysis and Prevention 2007, 39(1):94-105. 10.1016/j.aap.2006.06.008, 16919226.
125. Barkley RA, Murphy KR, Kwasnik D. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics 1996, 98(6 Pt 1):1089-1095.
126. Barkley RA, Murphy KR, Dupaul GJ, Bush T. Driving in young adults with attention deficit hyperactivity disorder: Knowledge, performance, adverse outcomes, and the role of executive functioning. Journal of the International Neuropsychological Society 2002, 8(5):655-672. 10.1017/S1355617702801345, 12164675.
127. Barkley RA, Cox D. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J Safety Res 2007, 38(1):113-128. 10.1016/j.jsr.2006.09.004, 17303170.
128. Swensen A, Birnbaum HG, Ben Hamadi R, Greenberg P, Cremieux PY, Secnik K. Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients. J Adolesc Health 2004, 35(4):346-349. e341.
129. Van Veen MM, Kooij JJS, Boonstra AM, Gordijn M, Van Someren EJW. Disrupted circadian rhythm in adults with ADHD and chronic sleep onset insomnia. Biol Psychiatry 2009, 67(11):1091-1096.
130. Gau SS, Kessler RC, Tseng WL, Wu YY, Chiu YN, Yeh CB, Hwu HG. Association between sleep problems and symptoms of attention-deficit/hyperactivity disorder in young adults. Sleep 2007, 30(2):195-201.
131. Barkley RA. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2002, 63(Suppl 12):10-15.
132. Ohlmeier MD, Peters K, Kordon A, Seifert J, Wildt BT, Wiese B, Ziegenbein M, Emrich HM, Schneider U. Nicotine and alcohol dependence in patients with comorbid attention-deficit/hyperactivity disorder (ADHD). Alcohol and alcoholism (Oxford, Oxfordshire) 2007, 42(6):539-543. 10.1093/alcalc/agm069, 17766314.
133. Young S, Gudjonsson G, Wells J, Asherson P, Theobald J, Oliver B, Scott C, Mooney A. Attention deficit hyperactivity disorder and critical incidents in a Scottish prison population Personality and Individual Differences. 2009, 46:265-269.
134. Mannuzza S, Klein RG, Moulton JL. Lifetime criminality among boys with attention deficit hyperactivity disorder: a prospective follow-up study into adulthood using official arrest records. Psychiatry Res 2008, 160(3):237-246. 10.1016/j.psychres.2007.11.003, 2581455, 18707766.
135. Foley HA, Carlton CO, Howell RJ. The relationship of attention deficit hyperactivity disorder and conduct disorder to juvenile delinquency: legal implications. Bull Am Acad Psychiatry Law 1996, 24(3):333-345.
136. Ziegler E, Blocher D, Bro J, Rosler M. Assessment of attention deficit hyperactivity disorder (ADHD) in prison inmates. [German]. Recht & Psychiatrie 2003, 21(1):17-21.
137. Young S, Gudjonsson G, Ball S, Lam J. Attention Deficit Hyperactivity Disorder (ADHD) in personality disordered offenders and the association with disruptive behavioural problems. Journal of Forensic Psychiatry & Psychology 2003, 14(3):491-505.
138. Minde K, Eakin L, Hechtman L, Ochs E, Bouffard R, Greenfield B, Looper K. The psychosocial functioning of children and spouses of adults with ADHD. J Child Psychol Psychiatry 2003, 44(4):637-646. 10.1111/1469-7610.00150, 12751853.
139. Weiss G, Hechtman L. Hyperactive children grown up. ADHD in children, adolescents and adults 1993, New York: Guilford Press, 2.
140. Mannuzza S, Klein RG, Bessler A, Malloy P, Hynes ME. Educational and occupational outcome of hyperactive boys grown up. JAmAcadChild AdolescPsychiatry 1997, 36(9):1222-1227.
141. Kessler RC, Lane M, Stang PE, Van Brunt DL, Trott GE. The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm. Psychol Med 2008, 21(1):1-11.
142. Antshel KM, Faraone SV, Maglione K, Doyle A, Fried R, Seidman L, Biederman J. Is adult attention deficit hyperactivity disorder a valid diagnosis in the presence of high IQ?. Psychol Med 2008, 24:1-11.
143. Mannuzza S, Klein RG. Long-term prognosis in attention-deficit/hyperactivity disorder. Child AdolescPsychiatrClinNAm 2000, 9(3):711-726.
144. Murphy KR, Barkley RA, Bush T. Young adults with attention deficit hyperactivity disorder: subtype differences in comorbidity, educational, and clinical history. J Nerv Ment Dis 2002, 190(3):147-157. 10.1097/00005053-200203000-00003, 11923649.
145. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 1991, 148(5):564-577.
146. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Jama: Journal of the American Medical Association 1998, 279(14):1100-1107.
147. Pliszka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatry 1998, 59(Suppl 7):50-58.
148. Kooij JJS, Burger H, Boonstra AM, van der Linden PD, Kalma LE, Buitelaar JK. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial. Psychol Med 2004, 34(6):973-982. 10.1017/S0033291703001776, 15554568.
149. Shekim WO, Asarnow RF, Hess E, Zaucha K. A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Comprehensive Psychiatry 1990, 31(5):416-425. 10.1016/0010-440X(90)90026-O, 2225800.
150. Biederman J. Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2004, 65(Suppl 3):3-7.
151. Rasmussen K, Almvik R, Levander S. Attention deficit hyperactivity disorder, reading disability, and personality disorders in a prison population. J Am Acad Psychiatry Law 2001, 29(2):186-193.
152. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up. AmJPsychiatry 1998, 155(4):493-498.
153. Wilens TE, Prince JB, Biederman J, Spencer TJ, Frances RJ. Attention-deficit hyperactivity disorder and comorbid substance use disorders in adults. Psychiatr Serv 1995, 46(8):761-763. 765.
154. Wilens TE. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. J Clin Psychiatry 2007, 68(Suppl 11):4-8.
155. Wilens TE, Biederman J, Mick E. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict 1998, 7(2):156-163.
156. Wilens TE, Hahesy AL, Biederman J, Bredin E, Tanguay S, Kwon A, Faraone SV. Influence of parental SUD and ADHD on ADHD in their offspring: preliminary results from a pilot-controlled family study. Am J Addict 2005, 14(2):179-187. 10.1080/10550490590924872, 16019966.
157. Fayyad J, De Graaf R, Kessler R, Alonso J, Angermeyer M, Demyttenaere K, De Girolamo G, Haro JM, Karam EG, Lara C, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007, 190:402-409. 10.1192/bjp.bp.106.034389, 17470954.
158. Breyer JL, Botzet AM, Winters KC, Stinchfield RD, August G, Realmuto G. Young Adult Gambling Behaviors and their Relationship with the Persistence of ADHD. J Gambl Stud 2009, 13:13.
159. Arnold LE. Sex differences in ADHD: conference summary. JAbnormChild Psychol 1996, 24(5):555-569.
160. Biederman J, Faraone SV, Spencer T, Wilens T, Mick E, Lapey KA. Gender differences in a sample of adults with attention deficit hyperactivity disorder. Psychiatry Res 1994, 53(1):13-29. 10.1016/0165-1781(94)90092-2, 7991729.
161. Biederman J, Faraone SV, Monuteaux MC, Bober M, Cadogen E. Gender effects on attention-deficit/hyperactivity disorder in adults, revisited. Biol Psychiatry 2004, 55(7):692-700. 10.1016/j.biopsych.2003.12.003, 15038997.
162. Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, Wilens TE, Frazier E, Johnson MA. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 2002, 159(1):36-42. 10.1176/appi.ajp.159.1.36, 11772687.
163. Kessler RC, Adler L, Berkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, et al. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry 2006, 163(4):716-723. 10.1176/appi.ajp.163.4.716, 2859678, 16585449.
164. Taylor EW, Keltner NL. Messy purse girls: Adult females and ADHD. Perspectives in Psychiatric Care 2002, 38(2):69-72. 10.1111/j.1744-6163.2002.tb00659.x, 12132633.
165. Dopfner M, Pluck J, Berner W, Fegert JM, Huss M, Lenz K, Schmeck K, Lehmkuhl U, Poustka F, Lehmkuhl G. Mental disturbances in children and adolescents in Germany. Results of a representative study:age,gender and rater effects. Zeitschrift fur Kinder-und Jugendpsychiatrie und Psychotherapie 1997, 25(4):218-233.
166. Newcorn JH, Halperin JM, Jensen PS, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott GR, Epstein JN, Greenhill LL, et al. Symptom profiles in children with ADHD: effects of comorbidity and gender. JAmAcadChild AdolescPsychiatry 2001, 40(2):137-146.
167. Nadeau KG, Quinn PO. Understanding women with AD/HD 2002, Silver Spring: Advantage Books.
168. Biederman J, Faraone SV, Mick E, Williamson S, Wilens TE, Spencer TJ, Weber W, Jetton J, Kraus I, Pert J, et al. Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J Am Acad Child Adolesc Psychiatry 1999, 38(8):966-975. 10.1097/00004583-199908000-00012, 10434488.
169. Judd F, Komiti A, Jackson H. How does being female assist help-seeking for mental health problems?. Aust N Z J Psychiatry 2008, 42(1):24-29. 10.1080/00048670701732681, 18058440.
170. Kooij JJS, Boonstra AM, Willemsen-Swinkels SHN, Bekker EM, Noord I, Buitelaar JK. Reliability, validity, and utility of instruments for self-report and informant report regarding symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in adult patients. Journal of Attention Disorders 2008, 11(4):445-458. 10.1177/1087054707299367, 18083961.
171. Brown TE, . (Ed) Attention-deficit disorders and comorbidities in children, adolescents, and adults 2000, Washington, DC: American Psychiatric Publishing, Inc, (Ed).
172. Applegate B, Lahey BB, Hart EL, Biederman J, Hynd GW, Barkley RA, Ollendick T, Frick PJ, Greenhill L, McBurnett K, et al. Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry 1997, 36(9):1211-1221. 10.1097/00004583-199709000-00013, 9291722.
173. Barkley RA. ADHD--Long-term course, adult outcome, and comorbid disorders. Attention deficit hyperactivity disorder: State of the science-best practices 2002, Civic Research Institute, Kington, New Jersey., Jensen Peter S, Cooper James R.
174. Barkley RA. Age dependent decline in ADHD: True recovery or statistical illusion?. The ADHD Report 1997, 5:1-5.
175. Brown TE. Executive functions and attention deficit hyperactivity disorder: Implications of two conflicting views. Internationalo Journal of Disability, Development and Education 2006, 53(1):35-46.
176. Barkley R, Murphy KR, Fischer M. ADHD in adults: what the science says 2007, New York: Guilford Press.
177. Murphy P, Schachar R. Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults. Am J Psychiatry 2000, 157(7):1156-1159.
178. Zucker M, Morris MK, Ingram SM, Morris RD, Bakeman R. Concordance of self- and informant ratings of adults' current and childhood attention-deficit/hyperactivity disorder symptoms. Psychol Assess 2002, 14(4):379-389. 10.1037/1040-3590.14.4.379, 12501563.
179. Danckaerts M, Heptinstall E, Chadwick O, Taylor E. Self-report of attention deficit and hyperactivity disorder in adolescents. Psychopathology 1999, 32(2):81-92. 10.1159/000029071, 10026452.
180. Sciutto MJ, Eisenberg M. Evaluating the evidence for and against the overdiagnosis of ADHD. J Atten Disord 2007, 11(2):106-113. 10.1177/1087054707300094, 17709814.
181. Hesslinger B, Tebartz van Elst L, Mochan F, Ebert D. Attention deficit hyperactivity disorder in adults - early vs. late onset in a retrospective study. Psychiatry Res 2003, 119:217-223. 10.1016/S0165-1781(03)00105-7, 12914893.
182. Karam RG, Bau CH, Salgado CA, Kalil KL, Victor MM, Sousa NO, Vitola ES, Picon FA, Zeni GD, Rohde LA, et al. Late-onset ADHD in adults: milder, but still dysfunctional. J Psychiatr Res 2009, 43(7):697-701. 10.1016/j.jpsychires.2008.10.001, 19007940.
183. Faraone SV, Kunwar A, Adamson J, Biederman J. Personality traits among ADHD adults: implications of late-onset and subthreshold diagnoses. Psychol Med 2009, 39(4):685-693. 10.1017/S0033291708003917, 2874959, 18588742.
184. Reinhardt MC, Benetti L, Victor MM, Grevet EH, Belmonte-de-Abreu P, Faraone SV, Rohde LA. Is age-at-onset criterion relevant for the response to methylphenidate in attention-deficit/hyperactivity disorder?. J Clin Psychiatry 2007, 68(7):1109-1116. 10.4088/JCP.v68n0720, 17685750.
185. Faraone SV, Biederman J, Doyle A, Murray K, Petty C, Adamson JJ, Seidman L. Neuropsychological studies of late onset and subthreshold diagnoses of adult attention-deficit/hyperactivity disorder. Biol Psychiatry 2006, 60(10):1081-1087. 10.1016/j.biopsych.2006.03.060, 16876139.
186. Faraone SV, Biederman J, Spencer T, Mick E, Murray K, Petty C, Adamson JJ, Monuteaux MC. Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid?. Am J Psychiatry 2006, 163(10):1720-1729. 10.1176/appi.ajp.163.10.1720, 17012682.
187. Kieling C, Kieling RR, Rohde LA, Frick PJ, Moffitt T, Nigg JT, Tannock R, Castellanos FX. The age at onset of attention deficit hyperactivity disorder. The Am J Psychiatry 167(1):14-16. 10.1176/appi.ajp.2009.09060796, 20068122.
188. Willoughby MT, Curran PJ, Costello EJ, Angold A. Implications of early versus late onset of attention-deficit/hyperactivity disorder symptoms. Journal of the American Academy of Child & Adolescent Psychiatry 2000, 39(12):1512-1519.
189. Todd RD, Huang H, Henderson CA. Poor utility of the age of onset criterion for DSM-IV attention deficit/hyperactivity disorder: recommendations for DSM-V and ICD-11. J Child Psychol Psychiatry 2008, 49(9):942-949. 10.1111/j.1469-7610.2008.01892.x, 18564071.
190. Barkley RA, Murphy KR, Fischer M. ADHD in adults. What the science says 2007, New York: The Guilford Press.
191. Barkley RA, Biederman J. Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997, 36(9):1204-1210. 10.1097/00004583-199709000-00012, 9291721.
192. Antshel KM. Attention-Deficit Hyperactivity Disorder in the context of a high intellectual quotient/giftedness. Dev Disabil Res Rev 2008, 14(4):293-299. 10.1002/ddrr.34, 19072757.
193. Chen W, Zhou K, Sham P, Franke B, Kuntsi J, Campbell D, Fleischman K, Knight J, Andreou P, Arnold R, et al. DSM-IV combined type ADHD shows familial association with sibling trait scores: a sampling strategy for QTL linkage. Am J Med Genet B Neuropsychiatr Genet 2008, 147B(8):1450-1460. 10.1002/ajmg.b.30672, 18189238.
194. Biederman J, Faraone SV, Mick E, Spencer T, Wilens T, Kiely K, Guite J, Ablon JS, Reed E, Warburton R. High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study. The Am J Psychiatry 1995, 152(3):431-435.
195. Ronald A, Simonoff E, Kuntsi J, Asherson P, Plomin R. Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample. Journal of child psychology and psychiatry, and allied disciplines 2008, 49(5):535-542. 10.1111/j.1469-7610.2007.01857.x, 18221348.
196. Willcutt EG, Pennington BF, Olson RK, DeFries JC. Understanding comorbidity: a twin study of reading disability and attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2007, 144B(6):709-714. 10.1002/ajmg.b.30310, 17440942.
197. Francks C, Fisher SE, Marlow AJ, MacPhie IL, Taylor KE, Richardson AJ, Stein JF, Monaco AP. Familial and genetic effects on motor coordination, laterality, and reading-related cognition. The Am J Psychiatry 2003, 160(11):1970-1977. 10.1176/appi.ajp.160.11.1970, 14594743.
198. Landgren M, Pettersson R, Kjellman B, Gillberg C. ADHD, DAMP and other neurodevelopmental/psychiatric disorders in 6-year- old children: epidemiology and co-morbidity. Dev Med Child Neurol 1996, 38(10):891-906.
199. Gillberg C. Deficits in attention, motor control, and perception: a brief review. Arch Dis Child 2003, 88(10):904-910. 10.1136/adc.88.10.904, 1719331, 14500312.
200. Upadhyaya HP. Substance use disorders in children and adolescents with attention-deficit/hyperactivity disorder: implications for treatment and the role of the primary care physician. Primary care companion to the Journal of clinical psychiatry 2008, 10(3):211-221. 10.4088/PCC.v10n0306, 2446489, 18615170.
201. Asherson P, Brookes K, Franke B, Chen W, Gill M, Ebstein RP, Buitelaar J, Banaschewski T, Sonuga-Barke E, Eisenberg J, et al. Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. The Am J Psychiatry 2007, 164(4):674-677. 10.1176/appi.ajp.164.4.674, 17403983.
202. Sobanski E. Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 2006, 256(Suppl 1):i26-31. 10.1007/s00406-006-1004-4, 16977548.
203. Sullivan MA, Rudnik-Levin F. Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations. Annals of the New York Academy of Sciences 2001, 931:251-270. 10.1111/j.1749-6632.2001.tb05783.x, 11462745.
204. Modestin J, Matutat B, Wurmle O. Antecedents of opioid dependence and personality disorder: attention-deficit/hyperactivity disorder and conduct disorder. Eur Arch Psychiatry Clin Neurosci 2001, 251(1):42-47. 10.1007/s004060170067, 11315518.
205. Ohlmeier MD, Peters K, Te Wildt BT, Zedler M, Ziegenbein M, Wiese B, Emrich HM, Schneider U. Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD). Alcohol and alcoholism (Oxford, Oxfordshire) 2008, 43(3):300-304. 10.1093/alcalc/agn014, 18326548.
206. Wilson JJ, Levin FR. Attention deficit hyperactivity disorder (ADHD) and substance use disorders. Curr Psychiatry Rep 2001, 3(6):497-506. 10.1007/s11920-001-0044-8, 11707164.
207. Wilens TE, Upadhyaya HP, Faraone SV, Biederman J. Impact of substance use disorder on ADHD and its treatment. J Clin Psychiatry 2007, 68(8):e20. 10.4088/JCP.0807e20, 17876905.
208. Goossensen MA, van de Glind G, Carpentier PJ, Wijsen RM, van Duin D, Kooij JJ. An intervention program for ADHD in patients with substance use disorders: preliminary results of a field trial. J Subst Abuse Treat 2006, 30(3):253-259. 10.1016/j.jsat.2005.12.004, 16616170.
209. Flory K, Lynam DR. The relation between attention deficit hyperactivity disorder and substance abuse: what role does conduct disorder play?. Clin Child Fam Psychol Rev 2003, 6(1):1-16. 10.1023/A:1022260221570, 12659448.
210. Kelly TM, Cornelius JR, Clark DB. Psychiatric disorders and attempted suicide among adolescents with substance use disorders. Drug and alcohol dependence 2004, 73(1):87-97. 10.1016/j.drugalcdep.2003.10.004, 14687963.
211. Kolpe M, Carlson GA. Influence of attention-deficit/hyperactivity disorder symptoms on methadone treatment outcome. Am J Addict 2007, 16(1):46-48. 10.1080/10601330601080073, 17364421.
212. Faraone SV, Wilens TE. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. The Journal of clinical psychiatry 2007, 68(Suppl 11):15-22.
213. Wilens TE. Attention deficit hyperactivity disorder and substance use disorders. The Am J Psychiatry 2006, 163(12):2059-2063. 10.1176/appi.ajp.163.12.2059, 17151154.
214. DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-IV. Checklists, Norms and Clinical Interpretation. 1998, New York: The Guilford Press.
215. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Scnik K, Spencer T, et al. The World Health Organization adult ADHD self-report scale (ASRS): A short screening scale for use in the general population. Psychol Med 2005, 35(2):245-256. 10.1017/S0033291704002892, 15841682.
216. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, Howes MJ, Jin R, Secnik K, Spencer T, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 2005, 35(2):245-256. 10.1017/S0033291704002892, 15841682.
217. Daigre C, Ramos-Quiroga JA, Valero S, Bosch R, Roncero C, Gonzalvo B, Nogueira M, Casas M. Adult ADHD Self-Report Scale (ASRS-v1.1) symptoms checklist in patients with substance use disorders. Actas Esp Psiquiatr 2009, 6(37):299-305.
218. Conners CK, Erhardt D, Sparrow E. Conners Adult ADHD Rating Scales (CAARS). Technical Manual 1999, New York: Multi Health Systems Inc.
219. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993, 150(6):885-890.
220. Rosler M, Retz W, Thome J, Schneider M, Stieglitz RD, Falkai P. Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 2006, 256(Suppl 1):i3-i11. 10.1007/s00406-006-1001-7, 16977549.
221. Epstein JN, Johnson DE, Conners CK. CAADID. The Conner's Adult ADHD Diagnostic Interview for DSM-IV 2001, MHS Inc.
222. Diagnostisch Interview voor ADHD (DIVA) bij volwassenen. , http://www.kenniscentrumadhdbijvolwassenen.nl
223. Boonstra AM, Oosterlaan J, Sergeant JA, Buitelaar JK. Executive functioning in adult ADHD: a meta-analytic review. PsycholMed 2005,
224. Krause J, Dresel SH, Krause KH, La Fougere C, Zill P, Ackenheil M. Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele. World J Biol Psychiatry 2006, 7(3):152. 10.1080/15622970500518444, 16861140.
225. Snyder SM, Hall JR. A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder. J Clin Neurophysiol 2006, 23(5):440-455.
226. Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry 2005, 57(3):229-238. 10.1016/j.biopsych.2004.11.009, 15691523.
227. McLean A, Dowson J, Toone B, Young S, Bazanis E, Robbins T, Sahakian B. Characteristic neurocognitive profile associated with adult attention-deficit/hyperactivity disorder. Psychol Med 2004, 34(4):681-692. 10.1017/S0033291703001296, 15099422.
228. Liotti M, Pliszka SR, Perez R, Luus B, Glahn D, Semrud-Clikeman M. Electrophysiological correlates of response inhibition in children and adolescents with ADHD: influence of gender, age, and previous treatment history. Psychophysiology 2007, 44(6):936-948. 10.1111/j.1469-8986.2007.00568.x, 17666028.
229. Kuntsi J, McLoughlin G, Asherson P. Attention deficit hyperactivity disorder. Neuromolecular Med 2006, 8(4):461-484. 10.1385/NMM:8:4:461, 17028370.
230. Barkley RA, Murphy KR. Impairment in occupational functioning and adult ADHD: the predictive utility of executive function (EF) ratings versus EF tests. Arch Clin Neuropsychol 2010, 25(3):157-173. 10.1093/arclin/acq014, 20197297.
231. Barkley RA, Fischer M. The unique contribution of emotional impulsiveness to impairment in major life activities in hyperactive children as adults. Journal of the American Academy of Child and Adolescent Psychiatry 2010, 49(5):503-513. 10.1097/00004583-201005000-00011, 20431470.
232. Golubchik P, Sever J, Zalsman G, Weizman A. Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial. Int Clin Psychopharmacol 2008, 23(4):228-231. 10.1097/YIC.0b013e3282f94ae2, 18446088.
233. Hooberman D, Stern TA. Treatment of attention deficit and borderline personality disorders with psychostimulants: case report. J Clin Psychiatry 1984, 45(10):441-442.
234. Reimherr FW, Williams ED, Strong RE, Mestas R, Soni P, Marchant BK. A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder. J Clin Psychiatry 2007, 68(1):93-101. 10.4088/JCP.v68n0113, 17284136.
235. Rosler M, Fischer R, Ammer R, Ose C, Retz W. A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 2009, 31:31.
236. Koesters M, Becker T, Kilian R, Fegert JM, Weinmann S. Limits of meta-analysis: methylphenidate in the treatment of adult attention-deficit hyperactivity disorder. J Psychopharmacol 2009, 23(7):733-744. 10.1177/0269881108092338, 18562416.
237. Meszaros A, Czobor P, Balint S, Komlosi S, Simon V, Bitter I. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis. The international journal of neuropsychopharmacology/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009, 12(8):1137-1147.
238. Prince JB. Pharmacotherapy of attention-deficit hyperactivity disorder in children and adolescents: update on new stimulant preparations, atomoxetine, and novel treatments. Child Adolesc Psychiatr ClinNAm 2006, 15(1):13-50.
239. Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A. Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry 2004, 13(Suppl 1):I102-116.
240. Young S, Amarasinghe J. Practioner review: Non-pharmacological treatments for ADHD: A lifespan perspective. Journal of Child Psychology and Psychiatry 2009,
241. Safren SA. Cognitive-behavioral approaches to ADHD treatment in adulthood. J Clin Psychiatry 2006, 67(Suppl 8):46-50.
242. Ramsay JR. Current status of cognitive-behavioral therapy as a psychosocial treatment for adult attention-deficit/hyperactivity disorder. Curr Psychiatry Rep 2007, 9(5):427-433. 10.1007/s11920-007-0056-0, 17915084.
243. Able SL, Johnston JA, Adler LA, Swindle RW. Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Medicine 2007, 37(1):1-11.
244. Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M. Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. J Clin Psychiatry 2006, 67(4):524-540. 10.4088/JCP.v67n0403, 16669717.
245. Torgersen T, Gjervan B, Rasmussen K. ADHD in adults: a study of clinical characteristics, impairment and comorbidity. Nord J Psychiatry 2006, 60(1):38-43. 10.1080/08039480500520665, 16500798.
246. Murphy K, Barkley RA. Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry 1996, 37(6):393-401. 10.1016/S0010-440X(96)90022-X, 8932963.
247. Rostain AL. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management. Postgrad Med 2008, 120(3):27-38. 10.3810/pgm.2008.09.1905, 18824823.
248. Murphy K. Psychosocial treatments for ADHD in teens and adults: a practice-friendly review. J Clin Psychol 2005, 61(5):607-619. 10.1002/jclp.20123, 15723366.
249. Biederman J, Wilens T, Mick E, Faraone SV, Weber W, Curtis S, Thornell A, Pfister K, Jetton JG, Soriano J. Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 1997, 36(1):21-29. 10.1097/00004583-199701000-00013, 9000777.
250. Faraone SV, Biederman J, Wilens TE, Adamson J. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults. Psychol Med 2007, 37(12):1743-1752. 10.1017/S0033291707000335, 17349106.
251. Wilens TE, Monuteaux MC, Snyder LE, Moore H, Whitley J, Gignac M. The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit/hyperactivity disorder: what does the literature tell us?. J Child Adolesc Psychopharmacol 2005, 15(5):787-798. 10.1089/cap.2005.15.787, 16262595.
252. Wilens TE. Does the medicating ADHD increase or decrease the risk for later substance abuse?. Rev Bras Psiquiatr 2003, 25(3):127-128. 10.1590/S1516-44462003000300001, 12975683.
253. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999, 104(2):e20. 10.1542/peds.104.2.e20, 10429138.
254. Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003, 111(1):179-185. 10.1542/peds.111.1.179, 12509574.
255. Kalbag AS, Levin FR. Adult ADHD and substance abuse: diagnostic and treatment issues. Substance use & misuse 2005, 40(13-14):1955-1981. 2043-1958.
256. Mariani JJ, Levin FR. Treatment strategies for co-occurring ADHD and substance use disorders. Am J Addict 2007, 16(Suppl 1):45-54. quiz 55-46, 10.1080/10550490601082783, 2676785, 17453606.
257. Volkow ND, Swanson JM. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry 2003, 160(11):1909-1918. 10.1176/appi.ajp.160.11.1909, 14594733.
258. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, Jayne M, Ma Y, Wong C. Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues. Neuroimage 2008, 39(3):1266-1273. 10.1016/j.neuroimage.2007.09.059, 18024160.
259. Faraone SV, Upadhyaya HP. The effect of stimulant treatment for ADHD on later substance abuse and the potential for medication misuse, abuse, and diversion. J Clin Psychiatry 2007, 68(11):e28. 10.4088/JCP.1107e28, 18052554.
260. Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Dopfner M, Faraone SV, Rothenberger A, et al. Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 2006, 15(8):476-495. 10.1007/s00787-006-0549-0, 16680409.
261. Adler LA, Spencer T, Brown TE, Holdnack J, Saylor K, Schuh K, Trzepacz PT, Williams DW, Kelsey D. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. J Clin Psychopharmacol 2009, 29(1):44-50. 10.1097/JCP.0b013e318192e4a0, 19142107.
262. Wilens TE, Haight BR, Horrigan JP, Hudziak JJ, Rosenthal NE, Connor DF, Hampton KD, Richard NE, Modell JG. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol Psychiatry 2005, 57(7):793-801.
263. Turner D. A review of the use of modafinil for attention-deficit hyperactivity disorder. Expert Rev Neurother 2006, 6(4):455-468. 10.1586/14737175.6.4.455, 16623645.
264. Kendall T, Taylor E, Perez A, Taylor C. Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance. Bmj 2008, 337(337):a1239. 10.1136/bmj.a1239, 18815170.
265. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2006, 59(9):829-835. 10.1016/j.biopsych.2005.09.011, 16373066.
266. Biederman J, Spencer T, Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol 2004, 7(1):77-97. 10.1017/S1461145703003973, 14733627.
267. Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, Mick E, Aleardi M, Herzig K, Faraone S. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57(5):456-463. 10.1016/j.biopsych.2004.11.043, 15737659.
268. Rosler M, Fischer R, Ammer R, Ose C, Retz W. A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 2009, 259(2):120-129. 10.1007/s00406-008-0845-4, 19165529.
269. Bouffard R, Hechtman L, Minde K, Iaboni-Kassab F. The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder. Can J Psychiatry 2003, 48(8):546-554.
270. Wilens TE, Spencer TJ. The stimulants revisited. Child AdolescPsychiatrClinNAm 2000, 9(3):573-603. viii.
271. Tossell JW, Greenstein DK, Davidson AL, Job SB, Gochman P, Lenane M, Nugent Iii TF, Gogtay N, Sporn AL, Rapoport JL. Stimulant drug treatment in childhood-onset schizophrenia with comorbid ADHD: an open-label case series. Journal of child and adolescent psychopharmacology 2004, 14(3):448-454. 10.1089/cap.2004.14.448, 15650502.
272. Nickels K, Katusic SK, Colligan RC, Weaver AL, Voigt RG, Barbaresi WJ. Stimulant medication treatment of target behaviors in children with autism: a population-based study. J Dev Behav Pediatr 2008, 29(2):75-81. 10.1097/DBP.0b013e31815f24f7, 2585372, 18478626.
273. Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, Vitiello B, Chuang SZ, Davies M, Ramadan Y, et al. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry 2007, 61(4):538-544. 10.1016/j.biopsych.2006.09.028, 17276750.
274. Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Child: care, health and development 2006, 32(5):575-583. 10.1111/j.1365-2214.2006.00631.x, 16919137.
275. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 2005, 62(11):1266-1274. 10.1001/archpsyc.62.11.1266, 16275814.
276. Bloch MH, Panza KE, Landeros-Weisenberger A, Leckman JF. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. Journal of the American Academy of Child and Adolescent Psychiatry 2009, 48(9):884-893. 10.1097/CHI.0b013e3181b26e9f, 19625978.
277. Poncin Y, Sukhodolsky DG, McGuire J, Scahill L. Drug and non-drug treatments of children with ADHD and tic disorders. European child & adolescent psychiatry 2007, 16(Suppl 1):78-88.
278. Kanner AM. The use of psychotropic drugs in epilepsy: what every neurologist should know. Seminars in neurology 2008, 28(3):379-388. 10.1055/s-2008-1079342, 18777484.
279. Ashton H, Gallagher P, Moore B. The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder. J Psychopharmacol 2006, 20(5):602-610. 10.1177/0269881106061710, 16478756.
280. Kollins SH. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. J Clin Psychiatry 2003, 64(Suppl 11):14-18.
281. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey S, Ashby C, Lieberman J, Hitzemann R. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 1995, 52(6):456-463.
282. Cox DJ, Humphrey JW, Merkel RL, Penberthy JK, Kovatchev B. Controlled-release methylphenidate improves attention during on-road driving by adolescents with attention-deficit/hyperactivity disorder. Journal of the American Board of Family Practice 2004, 17(4):235-239. 10.3122/jabfm.17.4.235, 15243010.
283. Larriviere D, Williams MA, Rizzo M, Bonnie RJ. Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee. Neurology 2009, 73(17):1406-1412. 10.1212/WNL.0b013e3181beecfe, 19776378.
284. Schubiner H. Substance abuse in patients with attention-deficit hyperactivity disorder: therapeutic implications. CNS Drugs 2005, 19(8):643-655. 10.2165/00023210-200519080-00001, 16097847.
285. Wilens TE, Adler LA, Weiss MD, Michelson D, Ramsey JL, Moore RJ, Renard D, Brady KT, Trzepacz PT, Schuh LM, et al. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend 2008, 96(1-2):145-154. 10.1016/j.drugalcdep.2008.02.009, 18403134.
286. Adler LA. Pharmacotherapy for adult ADHD. J Clin Psychiatry 2009, 70(5):e12. 10.4088/JCP.7129br5c, 19552859.
287. Madaan V. Lisdexamfetamine dimesylate for childhood ADHD. Drugs Today (Barc) 2008, 44(5):319-324. 10.1358/dot.2008.44.5.1215724, 18548134.
288. Weisler RH, Biederman J, Spencer TJ, Wilens TE, Faraone SV, Chrisman AK, Read SC, Tulloch SJ. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr 2006, 11(8):625-639.
289. Schachar RJ, Tannock R, Cunningham C, Corkum PV. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. JAmAcadChild AdolescPsychiatry 1997, 36(6):754-763.
290. Garland EJ. Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats. JPsychopharmacol 1998, 12(4):385-395.
291. Ramos-Quiroga JA, Bosch R, Castells X, Valero S, Nogueira M, Gomez N, Yelmo S, Ferrer M, Martinez Y, Casas M. Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate: a chart review of Spanish adults with attention-deficit hyperactivity disorder. CNS Drugs 2008, 22(7):603-611. 10.2165/00023210-200822070-00005, 18547128.
292. Adler LA, Spencer T, McGough JJ, Jiang H, Muniz R. Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD. J Atten Disord 2009, 12(5):449-459. 10.1177/1087054708320397, 19218542.
293. Faraone SV, Biederman J, Spencer T, Michelson D, Adler L, Reimherr F, Glatt SJ. Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis. Behav Brain Funct 2005, 1:16. 10.1186/1744-9081-1-16, 1262689, 16202140.
294. Kollins SH, Wilens TE, Fusillo S, Faraone SV, Upadhyaya HP. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines. J Atten Disord 2008, 12(2):115-125. 10.1177/1087054707311654, 18192623.
295. Jasinski DR, Faries DE, Moore RJ, Schuh LM, Allen AJ. Abuse liability assessment of atomoxetine in a drug-abusing population. Drug Alcohol Depend 2008, 95(1-2):140-146. 10.1016/j.drugalcdep.2008.01.008, 18328639.
296. Reimherr FW, Marchant BK, Strong RE, Hedges DW, Adler L, Spencer TJ, West SA, Soni P. Emotional dysregulation in adult ADHD and response to atomoxetine. Biol Psychiatry 2005, 58(2):125-131. 10.1016/j.biopsych.2005.04.040, 16038683.
297. Adler LA, Liebowitz M, Kronenberger W, Qiao M, Rubin R, Hollandbeck M, Deldar A, Schuh K, Durell T. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety 2009, 26(3):212-221. 10.1002/da.20549, 19194995.
298. Biederman J, Melmed RD, Patel A, McBurnett K, Donahue J, Lyne A. Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD. CNS Spectr 2008, 13(12):1047-1055.
299. Reimherr FW, Hedges DW, Strong RE, Marchant BK, Williams ED. Bupropion SR in adults with ADHD: A short-term, placebo-controlled trial. Neuropsychiatric Disease And Treatment 2005, 1(3):245-251. 2416755, 18568102.
300. Wilens TE, Spencer TJ, Biederman J, Girard K, Doyle R, Prince J, Polisner D, Solhkhah R, Comeau S, Monuteaux MC, et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. AmJPsychiatry 2001, 158(2):282-288.
301. Wilens TE, Biederman J, Prince J, Spencer TJ, Faraone SV, Warburton R, Schleifer D, Harding M, Linehan C, Geller D. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 1996, 153(9):1147-1153.
302. Popper CW. Antidepressants in the treatment of attention-deficit/hyperactivity disorder. JClinPsychiatry 1997, 58(Suppl 14):14-29.
303. Adler LA, Reingold LS, Morrill MS, Wilens TE. Combination pharmacotherapy for adult ADHD. Curr Psychiatry Rep 2006, 8(5):409-415. 10.1007/s11920-006-0044-9, 16968624.
304. Markowitz JS, Patrick KS. Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder. Clinical pharmacokinetics 2001, 40(10):753-772. 10.2165/00003088-200140100-00004, 11707061.
305. Ross BM, Seguin J, Sieswerda LE. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?. Lipids Health Dis 2007, 6(21):21. 10.1186/1476-511X-6-21, 2071911, 17877810.
306. Nadeau KG. Life management skills for the adult with ADD. A comprehensive guide to attention deficit disorder in adults: Research, diagnosis, and treatment 1995, 191-217. Philadelphia, PA: Brunner/Mazel, Inc, Nadeau KG.
307. Nadeau KG. ADD in the workplace: Career consultation and counseling for the adult with ADD. A comprehensive guide to attention deficit disorder in adults: Research, diagnosis, and treatment 1995, 308-334. Philadelphia, PA: Brunner/Mazel, Inc, Nadeau KG.
308. Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behaviour Research and Therapy 2005, 43(7):831-842. 10.1016/j.brat.2004.07.001, 15896281.
309. Aim B. Psychotherapy of attention deficit hyperactivity disorder in adults. Nervenheilkunde: Zeitschrift fur interdisziplinaere Fortbildung 2006, 25(6):459-464.
310. Weiss M, Safren SA, Solanto MV, Hechtman L, Rostain AL, Ramsay JR, Murray C. Research forum on psychological treatment of adults with ADHD. J Atten Disord 2008, 11(6):642-651. 10.1177/1087054708315063, 18417729.
311. Bramham J, Young S, Bickerdike A, Spain D, McCartan D, Xenitidis K. Evaluation of group cognitive behavioral therapy for adults with ADHD. J Atten Disord 2009, 12(5):434-441. 10.1177/1087054708314596, 18310557.
312. O'Connell RG, Bellgrove MA, Dockree PM, Robertson IH. Cognitive remediation in ADHD: effects of periodic non-contingent alerts on sustained attention to response. Neuropsychological rehabilitation 2006, 16(6):653-665. 10.1080/09602010500200250, 17127571.
313. Gevensleben H, Holl B, Albrecht B, Vogel C, Schlamp D, Kratz O, Studer P, Rothenberger A, Moll GH, Heinrich H. Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial. Journal of child psychology and psychiatry, and allied disciplines 2009, 50(7):780-789. 10.1111/j.1469-7610.2008.02033.x, 19207632.
314. Butnik SM. Neurofeedback in adolescents and adults with attention deficit hyperactivity disorder. J Clin Psychol 2005, 61(5):621-625. 10.1002/jclp.20124, 15723361.
315. Klingberg T, Fernell E, Olesen PJ, Johnson M, Gustafsson P, Dahlstrom K, Gillberg CG, Forssberg H, Westerberg H. Computerized training of working memory in children with ADHD--a randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry 2005, 44(2):177-186. 10.1097/00004583-200502000-00010, 15689731.
316. Arns M, de Ridder S, Strehl U, Breteler M, Coenen A. Efficacy of neurofeedback treatment in ADHD: the effects on inattention, impulsivity and hyperactivity: a meta-analysis. Clin EEG Neurosci 2009, 40(3):180-189.
317. Solanto MV, Marks DJ, Wasserstein J, Mitchell K, Abikoff H, Alvir JM, Kofman MD. Efficacy of Meta-Cognitive Therapy for Adult ADHD. The Am J Psychiatry 2010, 167(8):958-68. 10.1176/appi.ajp.2009.09081123, 20231319.
318. Chan E, Zhan C, Homer CJ. Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey. Arch Pediatr Adolesc Med 2002, 156(5):504-511.
319. Birnbaum HG, Kessler RC, Lowe SW, Secnik K, Greenberg PE, Leong SA, Swensen AR. Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin 2005, 21(2):195-206. 10.1185/030079904X20303, 15801990.
320. Bernfort L, Nordfeldt S, Persson J. ADHD from a socio-economic perspective. Acta Paediatr 2008, 97(2):239-245. 10.1111/j.1651-2227.2007.00611.x, 18254913.